skip to Cookie NoticeSkip to contents

Your health and safety remain our top priority: Learn about our Safe Care Commitment | Use our Prescreen app before arrival for faster entry | Read the COVID-19 Vaccine FAQs

Header Skipped.

Channing Genetics and Genetic Epidemiology Research

Genetics is the study of heredity and inherited characteristics and diseases. Genetic epidemiology studies the role of genetic factors in disease risk within and across populations.

Genetic factors have some influence on most human traits and diseases. Finding and understanding these genetic factors may lead to the discovery of new disease pathways, better prediction of risk or progression of disease or response to therapy, and novel therapies.

Investigators at the Channing Division of Network Medicine (CDNM) have made major contributions to genetics and genetic epidemiology, including:

  • Discovery of genetic risk factors for respiratory diseases and traits in large, multi-cohort genome-wide association studies (GWAS)
  • Whole exome and whole genome sequencing analyses
  • Development of statistical genetics methods
  • Integrative genomics, including molecular quantitative trait loci (QTL) studies of multiple “omics” data types (see Metabolomics, Transcriptomics)
  • Studies of the functional impact of observed genetic associations with diseases and traits (see Functional genomics)
  • Genetic studies of drug response (see Pharmacogenomics)

Current Research

We work in multidisciplinary teams, including disease experts, genetic epidemiologists, and statistical geneticists, to generate, quality control, and test genotyping and sequencing data for association in deeply phenotyped cohorts.

We apply a variety of computational tools for additional analyses, including fine mapping, shared heritability, identifying functional variants, and integrative genomics.

Achievements

Research at Channing identified genetics as a risk factor for COPD, identified some of the first genetic loci for asthma and COPD, and have since participated in or led the largest efforts in both diseases; developed family-based association tests (FBAT, PBAT) and family-based rare variant association (GESE); and performed some of the first integrative genomics studies in respiratory disease.

Recent research highlights of CDNM work in this area:

Genome-wide association studies

CDNM investigators have leadership roles and collaborate in many large GWAS consortia, including identification of:

Next-generation sequencing studies

We have been at the forefront of sequence data analysis, studying:

Bioinformatics and integrative genomics

Beyond association analyses, studies include:

Statistical methods development

With collaborators at the Harvard T.H. Chan School of Public Health, we work on development of new methods, such as:

  • Rare variant population stratification
  • Family-based analyses, including studies of rare variants